{"count": 24, "results": [{"_id": "39733990", "pmid": 39733990, "title": "KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy.", "journal": "J Mol Cell Cardiol", "authors": ["Wu Y", "Song Y", "Xie N", "Zhao W", "Lv J", "Zhang T", "Zhang Y", "Chen H", "Sun W", "Luo Z", "Cheng X", "Jiang T", "Wang Z", "Chen X", "Hu Y", "Fang Y", "Bai R", "Liu X", "He X", "Ren Z", "Huang J", "Xiong H", "Wang L"], "date": "2024-12-27T00:00:00Z", "doi": "10.1016/j.yjmcc.2024.12.010", "meta_date_publication": "2024 Dec 27", "meta_volume": "199", "meta_issue": "", "meta_pages": "62-77", "score": 50254.03, "text_hl": "CONCLUSIONS: This study provides the first evidence that transcription factor @GENE_KLF2 @GENE_10365 @@@KLF2@@@ serves as a negative regulator of @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@. Our findings highlight the therapeutic potential of enhancing @GENE_KLF2 @GENE_10365 @@@KLF2@@@ expression, particularly through @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ administration, as a promising strategy in the treatment of @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@.", "citations": {"NLM": "Wu Y, Song Y, Xie N, Zhao W, Lv J, Zhang T, Zhang Y, Chen H, Sun W, Luo Z, Cheng X, Jiang T, Wang Z, Chen X, Hu Y, Fang Y, Bai R, Liu X, He X, Ren Z, Huang J, Xiong H, Wang L. KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy. J Mol Cell Cardiol. 2024 Dec 27;199():62-77. PMID: 39733990", "BibTeX": "@article{39733990, title={KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy.}, author={Wu Y and Song Y and Xie N and Zhao W and Lv J and Zhang T and Zhang Y and Chen H and Sun W and Luo Z and Cheng X and Jiang T and Wang Z and Chen X and Hu Y and Fang Y and Bai R and Liu X and He X and Ren Z and Huang J and Xiong H and Wang L}, journal={J Mol Cell Cardiol}, volume={199}, pages={62-77}}"}}, {"_id": "19100119", "pmid": 19100119, "title": "[Simvastatin attenuated cardiac hypertrophy via inhibiting JAK-STAT pathways].", "journal": "Zhonghua Xin Xue Guan Bing Za Zhi", "authors": ["Wu Y", "Liu J"], "date": "2008-08-01T00:00:00Z", "meta_date_publication": "2008 Aug", "meta_volume": "36", "meta_issue": "8", "meta_pages": "738-43", "score": 50080.23, "text_hl": "[@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuated @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ via inhibiting JAK-STAT pathways].", "citations": {"NLM": "Wu Y, Liu J. [Simvastatin attenuated cardiac hypertrophy via inhibiting JAK-STAT pathways]. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Aug;36(8):738-43. PMID: 19100119", "BibTeX": "@article{19100119, title={[Simvastatin attenuated cardiac hypertrophy via inhibiting JAK-STAT pathways].}, author={Wu Y and Liu J}, journal={Zhonghua Xin Xue Guan Bing Za Zhi}, volume={36}, number={8}, pages={738-43}}"}}, {"_id": "18400235", "pmid": 18400235, "title": "Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.", "journal": "Life Sci", "authors": ["Liu J", "Shen Q", "Wu Y"], "date": "2008-05-07T00:00:00Z", "doi": "10.1016/j.lfs.2008.02.012", "meta_date_publication": "2008 May 7", "meta_volume": "82", "meta_issue": "19-20", "meta_pages": "991-6", "score": 50078.492, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ prevents @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ in vitro and in vivo via JAK/STAT pathway.", "citations": {"NLM": "Liu J, Shen Q, Wu Y. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. Life Sci. 2008 May 7;82(19-20):991-6. PMID: 18400235", "BibTeX": "@article{18400235, title={Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.}, author={Liu J and Shen Q and Wu Y}, journal={Life Sci}, volume={82}, number={19-20}, pages={991-6}}"}}, {"_id": "18758513", "pmid": 18758513, "title": "Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.", "journal": "Can J Physiol Pharmacol", "authors": ["Osorio JC", "Cheema FH", "Martens TP", "Mahmut N", "Kinnear C", "Gonzalez AM", "Bonney W", "Homma S", "Liao JK", "Mital S"], "date": "2008-09-01T00:00:00Z", "doi": "10.1139/y08-068", "meta_date_publication": "2008 Sep", "meta_volume": "86", "meta_issue": "9", "meta_pages": "633-42", "score": 50078.473, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ reverses @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ caused by disruption of the bradykinin 2 receptor.", "citations": {"NLM": "Osorio JC, Cheema FH, Martens TP, Mahmut N, Kinnear C, Gonzalez AM, Bonney W, Homma S, Liao JK, Mital S. Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. Can J Physiol Pharmacol. 2008 Sep;86(9):633-42. PMID: 18758513", "BibTeX": "@article{18758513, title={Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.}, author={Osorio JC and Cheema FH and Martens TP and Mahmut N and Kinnear C and Gonzalez AM and Bonney W and Homma S and Liao JK and Mital S}, journal={Can J Physiol Pharmacol}, volume={86}, number={9}, pages={633-42}}"}}, {"_id": "30767945", "pmid": 30767945, "pmcid": "PMC6383435", "title": "Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-kappaB (NF-kappaB)", "journal": "Med Sci Monit", "authors": ["Han Q", "Liu Q", "Zhang H", "Lu M", "Wang H", "Tang F", "Zhang Y"], "date": "2019-02-15T00:00:00Z", "doi": "10.12659/MSM.913244", "meta_date_publication": "2019 Feb 15", "meta_volume": "25", "meta_issue": "", "meta_pages": "1232-1241", "score": 50077.12, "text_hl": "These results suggest that the mechanism underlying the attenuation of @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is related to inhibition of NF-kappaB nuclear translocation by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Han Q, Liu Q, Zhang H, Lu M, Wang H, Tang F, Zhang Y. Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-kappaB (NF-kappaB) Med Sci Monit. 2019 Feb 15;25():1232-1241. PMID: 30767945", "BibTeX": "@article{30767945, title={Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-kappaB (NF-kappaB)}, author={Han Q and Liu Q and Zhang H and Lu M and Wang H and Tang F and Zhang Y}, journal={Med Sci Monit}, volume={25}, pages={1232-1241}}"}}, {"_id": "26150695", "pmid": 26150695, "pmcid": "PMC4484667", "title": "Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway", "journal": "Drug Des Devel Ther", "authors": ["Al-Rasheed NM", "Al-Oteibi MM", "Al-Manee RZ", "Al-Shareef SA", "Al-Rasheed NM", "Hasan IH", "Mohamad RA", "Mahmoud AM"], "date": "2015-06-23T00:00:00Z", "doi": "10.2147/DDDT.S86431", "meta_date_publication": "2015", "meta_volume": "9", "meta_issue": "", "meta_pages": "3217-29", "score": 50070.56, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ prevents @CHEMICAL_Isoproterenol @CHEMICAL_MESH:D007545 @@@isoproterenol@@@-induced @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ through modulation of the JAK/STAT pathway", "citations": {"NLM": "Al-Rasheed NM, Al-Oteibi MM, Al-Manee RZ, Al-Shareef SA, Al-Rasheed NM, Hasan IH, Mohamad RA, Mahmoud AM. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway Drug Des Devel Ther. 2015;9():3217-29. PMID: 26150695", "BibTeX": "@article{26150695, title={Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway}, author={Al-Rasheed NM and Al-Oteibi MM and Al-Manee RZ and Al-Shareef SA and Al-Rasheed NM and Hasan IH and Mohamad RA and Mahmoud AM}, journal={Drug Des Devel Ther}, volume={9}, pages={3217-29}}"}}, {"_id": "19515066", "pmid": 19515066, "title": "Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.", "journal": "Clin Exp Pharmacol Physiol", "authors": ["Guo WG", "Su FF", "Yuan LJ", "Yang GD", "Shi XQ", "Li RY", "Shu Q", "Liu XT", "Lu ZF", "Zheng QS"], "date": "2010-01-01T00:00:00Z", "doi": "10.1111/j.1440-1681.2009.05221.x", "meta_date_publication": "2010 Jan", "meta_volume": "37", "meta_issue": "1", "meta_pages": "40-5", "score": 50068.84, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits @GENE_AGT @GENE_24179 @@@angiotensin II@@@-induced @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac cell hypertrophy@@@: role of Homer 1a.", "citations": {"NLM": "Guo WG, Su FF, Yuan LJ, Yang GD, Shi XQ, Li RY, Shu Q, Liu XT, Lu ZF, Zheng QS. Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a. Clin Exp Pharmacol Physiol. 2010 Jan;37(1):40-5. PMID: 19515066", "BibTeX": "@article{19515066, title={Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.}, author={Guo WG and Su FF and Yuan LJ and Yang GD and Shi XQ and Li RY and Shu Q and Liu XT and Lu ZF and Zheng QS}, journal={Clin Exp Pharmacol Physiol}, volume={37}, number={1}, pages={40-5}}"}}, {"_id": "30443172", "pmid": 30443172, "pmcid": "PMC6216062", "title": "Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy", "journal": "Int J Med Sci", "authors": ["Su F", "Shi M", "Zhang J", "Zheng Q", "Zhang D", "Zhang W", "Wang H", "Li X"], "date": "2018-10-20T00:00:00Z", "doi": "10.7150/ijms.28106", "meta_date_publication": "2018", "meta_volume": "15", "meta_issue": "13", "meta_pages": "1508-1516", "score": 50065.754, "text_hl": "... @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ alleviated @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ in AAB @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Su F, Shi M, Zhang J, Zheng Q, Zhang D, Zhang W, Wang H, Li X. Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy Int J Med Sci. 2018;15(13):1508-1516. PMID: 30443172", "BibTeX": "@article{30443172, title={Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy}, author={Su F and Shi M and Zhang J and Zheng Q and Zhang D and Zhang W and Wang H and Li X}, journal={Int J Med Sci}, volume={15}, number={13}, pages={1508-1516}}"}}, {"_id": "27665951", "pmid": 27665951, "title": "Inhibition of inducible nitric oxide synthase (iNOS) by simvastatin attenuates cardiac hypertrophy in rats.", "journal": "Folia Morphol (Warsz)", "authors": ["Ahmed AM"], "date": "2017-01-01T00:00:00Z", "doi": "10.5603/FM.a2016.0043", "meta_date_publication": "2017", "meta_volume": "76", "meta_issue": "1", "meta_pages": "15-27", "score": 50064.137, "text_hl": "Inhibition of @GENE_NOS2 @GENE_24599 @@@inducible nitric oxide synthase@@@ (@GENE_NOS2 @GENE_24599 @@@iNOS@@@) by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ attenuates @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Ahmed AM. Inhibition of inducible nitric oxide synthase (iNOS) by simvastatin attenuates cardiac hypertrophy in rats. Folia Morphol (Warsz). 2017;76(1):15-27. PMID: 27665951", "BibTeX": "@article{27665951, title={Inhibition of inducible nitric oxide synthase (iNOS) by simvastatin attenuates cardiac hypertrophy in rats.}, author={Ahmed AM}, journal={Folia Morphol (Warsz)}, volume={76}, number={1}, pages={15-27}}"}}, {"_id": "10561812", "pmid": 10561812, "title": "Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.", "journal": "Clin Exp Pharmacol Physiol", "authors": ["Luo JD", "Zhang WW", "Zhang GP", "Guan JX", "Chen X"], "date": "1999-11-01T00:00:00Z", "doi": "10.1046/j.1440-1681.1999.03165.x", "meta_date_publication": "1999 Nov", "meta_volume": "26", "meta_issue": "11", "meta_pages": "903-8", "score": 50063.914, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ and @GENE_ACE @GENE_24310 @@@angiotensin-converting enzyme@@@ activity in @SPECIES_10116 @@@rats@@@ with @DISEASE_Aortic_Valve_Stenosis @DISEASE_MESH:D001024 @@@aortic stenosis@@@.", "citations": {"NLM": "Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol. 1999 Nov;26(11):903-8. PMID: 10561812", "BibTeX": "@article{10561812, title={Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.}, author={Luo JD and Zhang WW and Zhang GP and Guan JX and Chen X}, journal={Clin Exp Pharmacol Physiol}, volume={26}, number={11}, pages={903-8}}"}}]}